Amyris Signs Contract Manufacturing Agreement with Tate & Lyle
Amyris, Inc. (NASDAQ: AMRS) announced today that it has entered into a contract manufacturing agreement with Tate & Lyle Ingredients Americas, Inc., an affiliate of Tate & Lyle PLC (LSE:TATE.l - News). Under this arrangement, Tate & Lyle will produce farnesene at its facilities in Decatur, IL; the produced farnesene will be owned and distributed by Amyris.
This arrangement with Tate & Lyle expands Amyris's contracted production capacity. Amyris entered into a similar agreement in June 2010 with a facility of Biomin GMBH in Piracicaba, Brazil. Amyris expects to begin production of farnesene at the Biomin facility in the first half of 2011.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.